News & Updates
Filter by Specialty:

Atezolizumab plus chemo, bevacizumab improves survival in R/M cervical cancer
The addition of atezolizumab to first-line chemotherapy plus bevacizumab delivers significant improvements in survival among patients with PD-L1+ or PD-L1‒ persistent, recurrent, or metastatic (R/M) cervical cancer, results of a post hoc analysis of the BEATcc study have shown.
Atezolizumab plus chemo, bevacizumab improves survival in R/M cervical cancer
02 Sep 2025
HK data: Clozapine may increase infection risk in schizophrenia
Clozapine is associated with a moderately increased risk of infection vs olanzapine in patients with schizophrenia in Hong Kong, with the association being notably stronger in older age groups, according to researchers from the Department of Family Medicine and Primary Care at the University of Hong Kong (HKU).
HK data: Clozapine may increase infection risk in schizophrenia
02 Sep 2025
CtDNA-guided surveillance catches postoperative CRC recurrences early for curative treatment
For patients who have undergone curative resection for nonmetastatic colorectal cancer (CRC), performing circulating tumour DNA (ctDNA) methylation analysis during surveillance facilitates earlier detection of recurrences suitable for curative therapy, according to interim data from the phase III FIND trial.